Product
Currency:CNY
2024/FY
Stock NameRevenueRatio
药物开发及商业化阶段的产品和服务1.35B80.20%
药物研究阶段的产品和服务331.24M19.62%
Other3.1M0.18%
Industry
Currency:CNY
2024/FY
Stock NameRevenueRatio
药物研发与生产相关业务1.69B100.00%
Region
Currency:CNY
2024/FY
Stock NameRevenueRatio
Abroad1.24B73.43%
Domestic448.7M26.57%